Skip to content
Trending storyDeveloping

Conditional CTLH E3 ligase C-degron pathway tied to ribosome biogenesis

1 report1 sourceupdated 18 hours ago

Start here

Synthesis

A proteome-wide study by Grant et al., published in Molecular Cell on October 20, 2026, mapped C-degron activity across the human proteome using ORFeome libraries with different C-terminal architectures for comparative stability profiling. The work identified a conditionally regulated C-degron pathway controlled by the CTLH/Muskelin E3 ubiquitin ligase complex. One substrate, AAMP, is the human ortholog of yeast Sqt1 and functions as a chaperone for the ribosomal protein uL16. This connects nutrient status to the control of ribosome biogenesis, positioning the CTLH complex as a condition-sensitive regulator of a core cellular process. Which nutrients and signals gate the pathway, and the full range of its substrates, are open questions.

Written by a model from the reports · updated 2 hours ago

Coverage timeline

Follow the coverage to see the different angles.

Oct 20
  1. CellPick
    Proteome-wide C-degron activity profiling connects conditional regulation of the CTLH E3 ligase complex to ribosome biogenesis

    Grant et al. used ORFeome libraries with different C-terminal architectures for comparative stability profiling and identified a conditionally regulated C-degron pathway controlled by the CTLH/Muskelin E3 ubiquitin ligase complex. Its substrate AAMP is the human ortholog of yeast Sqt1 and acts as a uL16 chaperone, linking nutrient status to the regulation of ribosome biogenesis.

Coverage and heat for this story

Reports so far 1·Heat now 6·Peak heat 10 (Oct 20 08:00)·Reports, 24h +1

Cumulative reports
00.51
Heat index (decays)
0510Oct20Oct20Oct20Oct21

Two panels, same clock (pointer stays in sync): top is cumulative editorial reports — only rises; last point = All reports; slope = new reports that hour. Bottom is Live-board heatIndex — 7-day participants with a 24-hour half-life, so it can fall when talk cools.

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org